Prevalence of multidrug-resistant Staphylococcus aureus in diabetics clinical samples

  • S. RajuEmail author
  • Ajay Kumar Oli
  • S. A. Patil
  • R. Kelmani Chandrakanth
Original Paper


Antibiotic resistance in 40 Staphylococcus aureus clinical isolates from 110 diabetic patients (36%) was evaluated. Of these, 32 (80%) of the isolates showed multidrug-resistance to more than eight antibiotics and 35% isolates were found to be methicillin resistant S. aureus (MRSA). All 40 S. aureus strains (100%) screened from diabetic clinical specimens were resistant to penicillin, 63% to ampicillin, 55% to streptomycin, 50% to tetracycline and 50% to gentamicin. Where as low resistance rate was observed to ciprofloxacin (20%) and rifampicin (8%). In contrast, all (100%) S. aureus strains recorded susceptibility to teicoplanin, which was followed by vancomycin (95%). Genotypical examination revealed that 80% of the aminoglycoside resistant S. aureus (ARSA) have aminoglycoside modifying enzyme (AME) coding genes; however, 20% of ARSA which showed non-AME mediated (adaptive) aminoglycoside resistance lacked these genes in their genome. In contrast all MRSA isolates possessed mecA, femA genetic determinants in their genome.


Methicillin resistant Staphylococcus aureus Aminoglycoside modifying enzymes mecA and femA 


  1. Anupurba S, Sen MR, Nath G, Sharma BM, Gulati AK, Mohapatra TM (2003) Prevalence of methicillin resistant Staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh. Indian J Med Microbiol 21:49–51Google Scholar
  2. Arakere G, Nadig S, Swedberg G, Macaden R, Amarnath SK, Raghunath D (2005) Genotyping of methicillin-resistant Staphylococcus aureus strains from two hospitals in Bangalore, South India. J Clin Microbiol l43:3198–3202CrossRefGoogle Scholar
  3. CLSI (2009) Performance standard for antimicrobial susceptibility testing M100-S19Google Scholar
  4. Cottagnoud P, Cottagnoud M, Tauber MG (2003) Vancomycin acts synergistically with gentamycin against penicillin-resistant Pneumococci by increasing the intracellular penetration of gentamycin. Antimicrob Agents Chemother 47:144–147CrossRefGoogle Scholar
  5. Cui L, Ma X, Sato K, Okuma K, Tenover FC, Mamizuka EM, Gemmell CG, Kim M-N, Ploy M-C, Solh NE, Ferraz V, Hiramatsu K (2003) Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 41:5–14CrossRefGoogle Scholar
  6. Dang CN, Prasad YDM, Boulton AJM, Jude EB (2002) Methicillin resistant Staphylococcus aureus in the diabetic foot clinic: the problem is getting worse. Diabetologica 45:A4Google Scholar
  7. Goldstein EJ, Citron DM, Nesbit CA (1996) Diabetic foot infections, bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases. Diabetes Care 19:638–641CrossRefGoogle Scholar
  8. Gresham HD, Lowrance JH, Caver TE, Wilson BS, Cheung AL, Lindberg FP (2000) Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol 164:3713–3722Google Scholar
  9. Heurtier-Hartemann AJ, Robert S, Jacqueminet G, Van H, Golmard JL, Jarlier V, Grimaldi A (2004) Diabetic foot ulcer and -resistant organisms: risk factors and impact. Diabetic Med 21:710–715CrossRefGoogle Scholar
  10. Ida T, Okamoto R, Shimauchi C, Okubo T, Kuga A, Inoue M (2001) Identification of aminoglycoside-modifying enzymes by susceptibility testing: epidemiology of methicillin-resistant Staphylococcus aureus in Japan. J Clin Microbiol 39:3115–3121CrossRefGoogle Scholar
  11. Jeremy R, Lee JC (2005) The pathogenesis of Staphylococcus aureus infection in the diabetic NOD mouse. Diabetes 54:2904–2910CrossRefGoogle Scholar
  12. Kao SJ, You IL, Clewell DB, Donabedian SM, Zervos MJ, Petrin J, Shaw KJ, Chow JW (2000) Detection of the high-level aminoglycoside resistance gene aph(2″)-Ib in Enterococcus faecium. Antimicrob Agents Chemother 44:2876–2879CrossRefGoogle Scholar
  13. Karchmer A (2002) Microbiology and treatment of diabetic foot infections. In: Veves A, Giurini JM, LoGerfro FW (eds) The diabetic foot: medical and surgical treatment. Humana, Totowa, NJ, pp 207–219Google Scholar
  14. Kelmani Chandrakanth R, Raju S, Patil SA (2008) Aminoglycoside resistance mechanisms in multi-drug resistant Staphylococcus aureus clinical isolates. Curr Microbiol 56:558–562CrossRefGoogle Scholar
  15. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339(8):520–532CrossRefGoogle Scholar
  16. McMahon MM, Bistrian BR (1995) Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 9:1–9Google Scholar
  17. Mulligan ME, Murray-Leisure A, Ribner BS, Standiford HC, John JF, Korvick JA et al (1993) Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis and epidemiology with implications for prevention and management. Am J Med 94:313–328CrossRefGoogle Scholar
  18. Nadig S, Namburi P, Raghunath D, Arakere G (2006) Genotyping of methicillin-resistant Staphylococcus aureus isolates from Indian hospitals. Curr Sci 91:1364–1369Google Scholar
  19. Poole K (2005) Aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 49:479–487CrossRefGoogle Scholar
  20. Raju S, Kelmani Chandrakanth R, Patil SA (2007) High level oxacillin and gentamycin resistance with reduced susceptibility to vancomycin in Staphylococcus aureus carrying mecA and femA gene complex. Cur Microbiol 54:429–434CrossRefGoogle Scholar
  21. Roghmann MC, Siddiqui A, Plaisance K, Standiford H (2001) MRSA colonisation and the risk of MRSA bacteraemia in hospitalized patients with chronic ulcers. J Hosp Infect 47:98–103CrossRefGoogle Scholar
  22. Tentolouris N, Jude EB, Smirnof I, Knowles A, Boulton AJM (1999) Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med 16:767–771CrossRefGoogle Scholar
  23. Tsao S-M, Hsu C-C, Yin M-C (2006) Methicillin-resistant Staphylococcus aureus infection in diabetic mice enhanced inflammation and coagulation. J Med Microbiol 55:379–385CrossRefGoogle Scholar
  24. Wu SW, De Lencastre H, Tomasz A (2001) Recruitment of the mecA gene homologue of Staphylococcus sciuri into a resistance determinant and expression of the resistant phenotype in Staphylococcus aureus. J Bacteriol 183:2417–2424CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • S. Raju
    • 1
    • 3
    Email author
  • Ajay Kumar Oli
    • 1
  • S. A. Patil
    • 2
  • R. Kelmani Chandrakanth
    • 1
  1. 1.Department of BiotechnologyGulbarga UniversityGulbargaIndia
  2. 2.Department of NeuromicrobiologyNational Institute of Mental Health and Neuro SciencesBangaloreIndia
  3. 3.Department of Microbiology and Cell BiologyIndian Institute of ScienceBangaloreIndia

Personalised recommendations